Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Kordan W et al. | Effect of platelet activating factor (PAF) supplementation in semen extender on viability and ATP content of cryopreserved canine spermatozoa. | 2010 | Pol J Vet Sci | pmid:21370733 |
Donado E et al. | No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. | 2010 | Br J Clin Pharmacol | pmid:20406224 |
Saad MM et al. | Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils. | 2010 | Can J Anaesth | pmid:19882198 |
Wang L et al. | Three new compounds from Morus nigra L. | 2010 | J Asian Nat Prod Res | pmid:20552479 |
Grassi G et al. | Exogenous platelet-activating factor improves the motility of human spermatozoa evaluated with C.A.S.A.: optimal concentration and incubation time. | 2010 | J. Endocrinol. Invest. | pmid:20220291 |
Binder U et al. | The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans. | 2010 | Mol. Microbiol. | pmid:19889092 |
Ciprandi G and Cirillo I | Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. | 2010 Apr-Jun | J. Biol. Regul. Homeost. Agents | pmid:20487631 |
Ploppa A et al. | Local anesthetic effects on human neutrophil priming and activation. | 2010 Jan-Feb | Reg Anesth Pain Med | pmid:20048657 |
Michelotto PV et al. | Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. | 2010 Mar-Apr | J. Vet. Intern. Med. | pmid:20102491 |
Ha SW and Lee CS | Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. | 2010 May-Jun | Neurochem. Int. | pmid:20304020 |
Lenshof A and Laurell T | Emerging clinical applications of microchip-based acoustophoresis. | 2011 | J Lab Autom | pmid:22093301 |
Michelotto PV et al. | Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. | 2011 | Vet. J. | pmid:22108190 |
Nasopoulou C et al. | Fish polar lipids retard atherosclerosis in rabbits by down-regulating PAF biosynthesis and up-regulating PAF catabolism. | 2011 | Lipids Health Dis | pmid:22087726 |
Sánchez FA et al. | Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability. | 2011 | J. Biol. Chem. | pmid:21757745 |
Dombrowsky H et al. | Ingestion of (n-3) fatty acids augments basal and platelet activating factor-induced permeability to dextran in the rat mesenteric vascular bed. | 2011 | J. Nutr. | pmid:21775525 |
Tsuda M et al. | Platelet-activating factor and pain. | 2011 | Biol. Pharm. Bull. | pmid:21804199 |
Chan MV et al. | Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. | 2011 | Platelets | pmid:21806492 |
Zhou X and He P | Temporal and spatial correlation of platelet-activating factor-induced increases in endothelial [Ca²âº]i, nitric oxide, and gap formation in intact venules. | 2011 | Am. J. Physiol. Heart Circ. Physiol. | pmid:21873500 |
Alarcón P et al. | D-lactic acid interferes with the effects of platelet activating factor on bovine neutrophils. | 2011 | Vet. Immunol. Immunopathol. | pmid:21816488 |
Machado GB et al. | Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis. | 2011 | Respir. Res. | pmid:21819560 |
Drolet AM et al. | Platelet-activating factor induces Th17 cell differentiation. | 2011 | Mediators Inflamm. | pmid:22013287 |
Verouti SN et al. | PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. | 2011 | Atherosclerosis | pmid:21920519 |
Tsantila N et al. | In vitro and in vivo effects of statins on platelet-activating factor and its metabolism. | 2011 | Angiology | pmid:20805097 |
Zong RK and Liu J | [Effects of Chinese herbal medicine Xinfeng Capsule on expressions of platelet-activating factor and interleukins 6 and 17 in peripheral blood of rats with adjuvant arthritis]. | 2011 | Zhong Xi Yi Jie He Xue Bao | pmid:22152774 |
Smit JJ et al. | Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses. | 2011 | PLoS ONE | pmid:22194949 |
Parrill AL et al. | Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7. | 2011 | BMC Biochem. | pmid:22177013 |
Jönsson F et al. | Mouse and human neutrophils induce anaphylaxis. | 2011 | J. Clin. Invest. | pmid:21436586 |
Côrte-Real R et al. | The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus. | 2011 | J. Insect Physiol. | pmid:21439293 |
Li XJ et al. | [Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance]. | 2011 | Zhonghua Bing Li Xue Za Zhi | pmid:21426810 |
Leistad L et al. | Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. | 2011 | Scand. J. Rheumatol. | pmid:21417548 |
Xu LF et al. | Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. | 2011 | Arch. Pharm. Res. | pmid:21380808 |
Aktan I et al. | PKC isoenzymes in equine platelets and stimulus induced activation. | 2011 | Vet. Immunol. Immunopathol. | pmid:21513989 |
Jiang W et al. | [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro]. | 2011 | Zhonghua Fu Chan Ke Za Zhi | pmid:22333285 |
Kang NI et al. | Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock. | 2011 | J. Immunol. | pmid:21531890 |
Tang WZ et al. | Dimeric prenylated C6-C3 compounds from the stem bark of Illicium oligandrum. | 2011 | J. Nat. Prod. | pmid:21524101 |
Ma SG et al. | Four new phenolic diglycosides from the roots of Illicium oligandrum. | 2011 | Carbohydr. Res. | pmid:21524732 |
Yang AP and Chen Q | [Correlation between blood-stasis tongue figure and platelet activating factor (PAF) and acetyl hydrolase of PAF (PAF-AH) in patients with primary dysmenorrhea]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21485072 |
McHowat J et al. | Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21228317 |
Orlando RC et al. | Esophageal disease: updated information on inflammation. | 2011 | Ann. N. Y. Acad. Sci. | pmid:21950828 |
Frisardi V et al. | Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. | 2011 | Prog. Lipid Res. | pmid:21703303 |
Fang W et al. | Platelet activating factor induces blood brain barrier permeability alteration in vitro. | 2011 | J. Neuroimmunol. | pmid:20870297 |
Fragel-Madeira L et al. | Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S/G2 transition. | 2011 | PLoS ONE | pmid:21298035 |
Garland RC et al. | Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. | 2011 | FASEB J. | pmid:21257713 |
Musto AE and Samii M | Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. | 2011 | Epilepsia | pmid:21204830 |
Liao HJ et al. | Two new ginkgolides from the leaves of Ginkgo biloba. | 2011 | Planta Med. | pmid:21614751 |
Penna C et al. | Platelet activating factor: the good and the bad in the ischemic/reperfused heart. | 2011 | Exp. Biol. Med. (Maywood) | pmid:21378031 |
Brooks AC et al. | CXCL8 attenuates chemoattractant-induced equine neutrophil migration. | 2011 | Vet. Immunol. Immunopathol. | pmid:21040981 |
Greiner C et al. | 2-(4-(Biphenyl-4-ylamino)-6-chloropyrimidin-2-ylthio)octanoic acid (HZ52)--a novel type of 5-lipoxygenase inhibitor with favourable molecular pharmacology and efficacy in vivo. | 2011 | Br. J. Pharmacol. | pmid:21506958 |
Kennedy MA et al. | Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor. | 2011 | PLoS Genet. | pmid:21347278 |
Kim HA et al. | Mechanisms of platelet-activating factor-induced enhancement of VEGF expression. | 2011 | Cell. Physiol. Biochem. | pmid:21325822 |